Johnson & Johnson was formed in 1886 and is a pharmaceutical, medical device, and consumer packaged goods firm. This American multinational corporation, located in New Brunswick, New Jersey, employs around 132,000 people as of 2020. It operates in over 60 countries and has over 250 subsidiaries.

Since 2012, Johnson & Johnson has been the most profitable of the big biotech companies. The company achieved $82.059 billion in revenue in 2019. On April 14, 2020, Johnson & Johnson reported first-quarter sales of $20.7 billion, up 3.3 percent from the previous year. In the second and third quarters of 2020, the company made $18.3 billion and $21.1 billion, respectively. COVID-19's impact was evident in a 10.8% decline in revenue in the second quarter. The company's 1.7 percent gain in the third-quarter financial report for 2020 reflects the strength of Johnson & Johnson's business model, the quality and breadth of its portfolio, and the company's constant commitment to innovation. In the first, second, and third quarters of 2020, Johnson & Johnson produced $60.1 billion in revenue.

Because of the combination of current technology and their experience, incredible things are possible. J&J's consumer business is working on digital solutions to help customers track the condition of their skin. Pharmaceutical researchers are utilizing AI to design life-saving drugs, while medical device engineers are 3D printing prosthetic joints that are personalized for each patient. Consider what the rest of their 134,000-strong workforce is accomplishing across 260 companies in more than 60 countries. They are redefining what it means to be a significant business in today's world.

Founded: 1886
Headquarters: New Brunswick, NJ
Market Cap: $498.44B AUD ($368.91B USD)
Website: https://www.jnj.com/

Novartis, based in Switzerland, is a worldwide healthcare and pharmaceutical firm. Novartis concentrates on patented medicines, generic drugs, and eye care, all of which are sectors in which they have the necessary inventive competence and global scale to compete effectively. Simultaneously, Novartis is expanding its foothold in emerging markets such as Asia, Africa, and Latin America, where high-quality medications and healthcare are in great demand. They employ roughly 103,000 individuals throughout the world as of 2019.

Novartis is helping people live longer, healthier lives by rethinking medicine. It uses breakthrough science and digital technologies to deliver revolutionary solutions in areas of acute medical need as a leading global medicines firm. They routinely rank among the world's top corporations in terms of research and development investment in their effort to identify new therapies. Throughout 1 billion people use Novartis' medications around the world, and the company is continually looking for new methods to expand access to its newest therapies. Novartis employs about 125 000 employees from over 140 different countries.

Founded: December 1996
Headquarters: Basel, Switzerland
Market Cap: $269.04B AUD ($199.09B USD)
Website: http://www.novartis.com

Abbot Laboratories is the second of two companies that resulted from the first Abbot Laboratories' separation in 2013. Abbot Laboratories is in charge of the company's diagnostic and medical technology divisions, while AbbVie is in charge of pharmaceutical research.

On our list of the top 10 pharmaceutical companies in the United States, Abbot Laboratories is rated sixth. Abbott Laboratories, which was founded in 1888 and is based in Lake Bluff, Illinois, distributes medical equipment, diagnostics, branded generic pharmaceuticals, and nutritional products. Abbott's products are used to diagnose and monitor illnesses such as HIV, hepatitis, cancer, heart failure, and metabolic disorders.

In December of the same year, Abbot Laboratories had a revenue of $31.9 billion and employed around 107,000 employees. In the first quarter of 2020, Abbot's worldwide sales of $7.7 billion increased 2.5 percent on a reported basis and 4.3 percent organically. In the second quarter of 2020, the company's worldwide sales of $7.3 billion declined 8.2 percent on a reported basis and 5.4 percent organically, excluding the impact of foreign exchange. In the third quarter of 2020, global sales of $8.9 billion increased 9.6% on a reported basis and 10.6% organically, excluding the impact of foreign exchange.

Founded: 1888
Headquarters: Chicago, Illinois, United States
Market cap: $194.37B AUD ($143.91B USD)
Website: https://www.abbott.com/

Medtronic may have moved its headquarters to Dublin, Ireland for tax reasons in 2015, but the company has been headquartered in Minnesota for more than 60 years and still gets the majority of its sales from the US healthcare system.

Medtronic, with 90,000 employees in 150 countries, is at the cutting edge of medical technology. Despite the fact that Medtronic's revenues declined 4% in 2020, the results were consistent with the impact of delayed treatments across the medical device business due to the pandemic. Despite a number of recent approvals and delayed product releases, Medtronic's pipeline continues to drive therapeutic innovation.

Despite Covid-19, Micra VR and Micra AV, the world's smallest pacemakers for bradyarrhythmia management, were released in the United States and performed successfully. The firm will continue to invest in innovation in the future in order to maintain its industry-leading pipeline of unique ideas. They've also undertaken a number of acquisitions, including Digital Surgery, Medicrea, and Companion Medical, all of which will aid in their future expansion.

It is predicted to generate $30.5 billion in total revenue by 2020, and it employs over 100,000 people worldwide.

Founded: 1949
Headquarters: Dublin, Ireland
Revenue: 30,12 Billion USD
Website: https://europe.medtronic.com/xd-en/index.html

Cochlear Limited, situated in Sydney, was founded in 1981 and is one of Australia's leading medical device firms. The firm controls more than two-thirds of the global market for hearing implants. Cochlear now controls over two-thirds of the global hearing implant industry, with over 250,000 patients having received a Cochlear implant since 1982.

In 2002 and 2003, Cochlear was voted Australia's most inventive firm, and Forbes named it one of the world's most innovative companies in 2011.

They've distributed over 600,000 implanted devices. Through their families, friends, coworkers, instructors, and other connections, each winner contributes to a worldwide community of millions. They're not only linked to their own communities; they're also linked to one another and to Professor Clark's youthful ambition to help people hear.

They want to provide people with the finest possible hearing experience for the rest of their lives, as well as access to cutting-edge future technology. They recognize the honor of introducing them to a world where they can hear. They also listen, respond, and change with the times in order to keep bringing hearing to everyone who needs it.

Founded: 1981

Headquarters: North Ryde, NSW

Market Capitalization (Market Cap) – $12B AUD

Website: https://microsites.prod.cms.cochlear.cloud/vn